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Positron detection in silica monoliths for
miniaturised quality control of PET radiotracers†
Mark D. Tarn,‡ab Dzmitry Maneuski,‡*c Richard Alexander,§d Nathaniel J. Brown,d
Val O’Shea,c Sally L. Pimlott,e Nicole Pamme*b and Stephen J. Archibald*ab
We demonstrate the use of the miniaturised Medipix positron sensor
for detection of the clinical PET radiotracer, [68Ga]gallium-citrate, on a
silica-based monolith, towards microfluidic quality control. The system
achieved a far superior signal-to-noise ratio compared to conventional
sodium iodide-based radio-HPLC detection and allowed real-time
visualisation of positrons in the monolith.
Positron emission tomography (PET) is a powerful medical
imaging technique with unrivalled sensitivity, and is used for
diagnostic imaging in oncology, cardiology and neurology.1,2
Radiotracers are molecules labelled with positron-emitting
radioisotopes (e.g. 11C, 18F or 68Ga) that are used in PET imaging.
The current standard production method for the most commonly
used radiotracer ([18F]fluorodeoxyglucose) is to generate it in large
batches and then transport to imaging centres. However, this form
of centralised production limits the number of different radiotracers
available and precludes responsive imaging, limiting the scope of
clinical investigations. In recent years, the concepts of decentralised
production3 and dose-on-demand4–6 radiotracer synthesis have
gained interest in the move towards stratified patient treatment,
wherein a single dose of an appropriate tracer would be generated
for a specific patient. The most feasible route to this is via
microfluidic platforms,7 but while on-chip synthesis of some
radiotracers has been demonstrated,8,9 miniaturisation of the
subsequent quality control (QC) steps onto an integrated lab-on-
a-chip microfluidic device has not been achieved.
We are developing an integrated microfluidic platform for
the miniaturised QC testing of PET radiopharmaceuticals, with a
view to short analysis times, low sample volumes, and minimal
radiation exposure to operating staff. Many of the necessary QC tests
require the separation and radiodetection of sample components via
thin layer chromatography (radio-TLC) or high performance
liquid chromatography (radio-HPLC).10,11 Silica-based monoliths
have recently become popular for chromatography,12 including
quality control in pharmaceutical production,13 and have proven
successful in a variety of microfluidic applications.14 As such,
they have great potential in the microfluidic QC testing of PET
radiotracers. However, the requirement to detect radioactivity in
such a miniaturised separation system brings further challenges.
While several examples of on-chip radiodetection can be
found in the literature, including phosphor imaging,15 Cerenkov
light detection,16 imaging with plastic17 or inorganic scintillators,18,19
solid-state beta-particle cameras,20 PIN photodiode arrays,21
and liquid scintillator-containing microchannels interfaced to
a PMT,22 these methods can suffer from a variety of issues
including slow response times, low sensitivity, high cost, and/or
complexity of fabrication. Here, we present the first application
of a Medipix-based positron sensor23 for the detection of radio-
activity in silica-basedmonoliths (Fig. 1) towardsminiaturisation of
QC testing.
The Medipix2 sensor is a hybrid silicon pixel detector capable of
direct positron detection that was originally developed within the
high energy particle physics community at the European Organiza-
tion for Nuclear Research (CERN).24 Featuring a 65k single-photon
counting pixel array with a square pixel size of 55 mm, on a 14 
14 mm2 detection area, the sensor can act as a real-time camera
for positrons. This feature, combined with the sensor’s small
size, makes it an ideal candidate for on-chip radiodetection.
Herein, we evaluate its potential by studying the passage of
gallium-68 solutions25,26 through silica-based monoliths12,27
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designed for purification and chromatographic separation in a
future integrated microfluidic QC platform.
Since positrons can only travel a short distance before
annihilation with an electron (up to several mm dependent on
the positron energy),28 an initial study was performed to determine
the effect of distance between a radioisotope and the positron
detector. Microscope cover slips (150 mm thickness) were stacked
on top of the sensor in order to vary the glass thickness between the
detection area and the fluorine-18 (t1
2
= 109.7 min) radioisotope
solution (see Fig. S1a, ESI†). Fluorine-18 was used initially as it has
a low positron energy compared to the other common PET isotopes
(18F positron end point energy of 634 keV compared to 961 keV and
1899 keV for the positron emitted from 11C and 68Ga, respectively)29
and therefore represents a worst case scenario in terms of positron
penetration distance. A 20 mL droplet of fluorine-18 was pipetted
onto the cover slip stack (Fig. S1a in the ESI†), with thickness varied
from 150 mm to 900 mm, and the resultant signal was counted for
600 s, with an acquisition time of 0.1 s. The Medipix was operated
in ‘‘counting’’ mode rather than ‘‘integration’’ mode, enabling
higher signal-to-noise ratios compared to other detectors that
employ the latter mode. A low energy level threshold was set to
just above the noise level of the detector (equivalent to 4.5 keV
X-ray), with no high threshold level applied. The results (see
Fig. S1b–h, ESI†) clearly demonstrated the expected decrease in
signal intensity as the distance between the radioisotope and
sensor was increased and so more positrons had annihilated
prior to reaching the detector surface. Nonetheless, even at the
maximum distance tested of 900 mm, positron signals could
still be detected.
The next step was to determine the positron detector’s sensitivity
to gallium-68 (t1
2
= 68 min). A solution of 68Ga-citrate, which is used
for PET imaging of inflammation, infection, and tumours,30,31 was
prepared in order to determine the detector’s sensitivity to the
gallium-68 radioisotope. A length of narrow bore Tygon tubing
(254 mm ID, 762 mm OD) was fixed over the sensor area, yielding a
detection volume of 709 nL and distance between the sensor and
the radioisotope of 254 mm. The tubing was filled via syringe with
68Ga-citrate solutions of varying activity levels, and 100 frames of
the detector response were recorded (1.0 s integration time). The
results are shown in Fig. 2, and demonstrate excellent linearity of
signal with activity levels (in MBq mL1). The data is also shown
replotted on a linear scale in Fig. S2 (ESI†). For comparison, a
clinical PET scan typically requires around 370 MBq (10 mCi), and
so assuming a maximum injection volume of about 10 mL the
expected activity levels during purification and quality control
would be a minimum of 37 MBq mL1. With this in mind, the
positron detector was able to detect clinically relevant levels of
activity in volumes of hundreds of nanolitres.
Subsequently, tests were performed to determine whether
the detector was capable of detecting injected plugs of activity
as they flowed through a monolithic column, with a view
towards monolithic radio-TLC and radio-HPLC applications.
Porous silica monoliths were prepared as described in the
literature32 and moulded such that they had a thin but flat
shape (14 mm long  4 mm wide  1.5 mm thick). This shape
was designed to restrict the monolith length to the dimensions
of the detector area, while limiting the number of undetected
positrons by keeping the monolith thin. Following fabrication,
monoliths were encased in PTFE heat-shrink tubing (1.27 mm
ID, 1.87 mm OD) that allowed it be connected to a flow system,
and the monolith was fixed onto the positron detector area. The
monolith was connected at one end to a sample injection system
comprising two syringe pumps and a four-way cross-piece
(Fig. 1c and Fig. S3, ESI†). The other end of the monolith tubing
was connected to a conventional 100 sodium iodide crystal (NaI)/
photomultiplier tube (PMT) radio-HPLC detector (PN-FXX-03
NaI/PMT, Dual Scan-RAM, LabLogic Systems Ltd, UK), which
detects the 511 keV gamma rays produced by positron annihilation,
for direct comparison of detection signals.
Solutions of 68Ga-citrate were prepared and then injected
into the monolith by first drawing the solution through the
cross-piece perpendicular to the direction of the silica monolith,
then halting that flow and applying flow in the direction of the
monolith (see Fig. S4, ESI†). This allowed injection of a plug of
68Ga-citrate ofB17 nL, based on the cross-piece dimensions. Four
injections were performed in 0.1M citric acid solution with varying
68Ga-citrate activities (6–15 MBq mL1, yielding 101–254 Bq in
17 nL) and flow rates (50 and 200 mL min1), with the sample
first passing through the monolith for detection via the positron
Fig. 1 (a) Silica-based monolithic column encased in heat-shrink tubing.
(b) Medipix positron detector, featuring a 14  14 mm2 sensor area.
(c) Schematic of the experimental setup, with the monolith placed above
the Medipix sensor, and featuring a cross-injection system and a standard
sodium iodide radio-HLPC detector.
Fig. 2 Plot showing the linearity of the positron detection signal with
varying radioactivity levels of the 68Ga-citrate radiotracer on a log scale.
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detector, then passing through the NaI/PMT radio-HPLC detector.
The integration time of each detector was set to 1 second. Fig. 3
shows the results from one of the injections (15 MBq mL1,
200 mL min1), with the blue signal from the positron detector
and the red signal from the NaI/PMT radio-HPLC detector (note
that they are on different scales). The positron detector clearly
shows a significant increase in detection signal for the 68Ga-citrate
peak compared to the radio-HPLC detector, but also demonstrates
a substantial increase in the signal-to-noise (S/N) ratio of 14 for
the positron detector and 3 for the radio-HPLC detector. Thus,
not only was the positron sensor capable of detecting activity in
real-time as it passed through a monolith, but also that its
performance was vastly superior to standard detectors. Fig. 3
(and the video labelled ‘‘1-Ga68 injection 1’’ in the ESI†) also
shows images taken from the positron detector as the 68Ga-citrate
plug first passed through the monolith and after the plug had
finished passing through. The tracks of the positrons can clearly be
seen on the first image, demonstrating the characteristic ‘‘random-
walk’’ motion of the positrons.
The positron detector and radio-HPLC signals for all four
injections of 68Ga-citrate are shown in Fig. S5 and S6 (ESI†)
(plotted on different scales to show differences in signal intensity
and S/N ratio, respectively), and the videos of the positron
detection signals for each injection have been included in the
ESI.† The resultant S/N ratios are shown in Table S2 (ESI†).
While the radio-HPLC signals had S/N ratios ranging from 3 to 7,
those of the positron detector ranged from a minimum of 10 to a
far superior 48. The wide range of S/N ratios for the positron
detector is due to improvements to the manual sample injections
as a result of practice over the course of the tests, and makes clear
the need for optimisation of the injection system. All of these
aspects could be investigated in future tests. It is evident, however,
that while the conventional NaI/PMT radio-HPLC detector was
nearing its limits at the levels of activity being analysed, the
positron detector was more than capable of detecting these low
levels in real-time in very small volumes of solution. These results
highlight the great potential for this detection system for use in
microfluidic systems, whilst also having the advantage of visualising
the activity rather than only detecting a signal. The positron
detection images shown in Fig. 3 and 4 also demonstrate very
limited sensitivity to gamma rays emitted upon annihilation of the
positrons with electrons. Hence, unlike a conventional NaI/PMT
gamma detector, no shielding is required for the positron detector,
ensuring a simple setup with a small footprint.
In a final test, the ability to monitor the trapping and release
of gallium-68 on the silica monolith was investigated. A solution of
68Ga3+ was prepared as 68GaCl3 and loaded into the cross-piece of
the sample injection setup as described earlier. The solution was
then injected into the monolith at 50 mL min1 in a mobile phase
of sodium phosphate (0.4 M). Fig. 4a shows the build-up of 68Ga3+
(11 MBq mL1) over time as it became trapped at the start of the
monolith. However, when the mobile phase was then changed to
0.1 M citric acid (at 50 mL min1), the gallium-68 was eluted from
the monolith and successfully monitored using the positron
Fig. 3 Plot of 68Ga-citrate radioactive emissions as it passed through the
monolithic column. The blue signal shows the signal from the positron
detector below the monolith, while the red signal was taken from a flow-
through NaI/PMT radio-HPLC detector. Note that the plots are on different
scales. Inset are images (14  14 mm2) taken from the detector at different
time points.
Fig. 4 Trap and release of 68Ga3+ on the silica-based monolith, with the positron detector showing the activity in real-time. (a) Trapping in phosphate
solution (0.4 M). (b) Release in citric acid (0.1 M). The flow of solution was right-to-left in the images.
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detector (Fig. 4b). Videos of these processes (‘‘5-Trapping of 68Ga’’
and ‘‘6-Release of 68Ga’’) obtained via the positron detector can be
found in the ESI.†
In summary, we have demonstrated, for the first time, the
monitoring of gallium-68 solutions in silica monoliths in a
flow-based system using a small-footprint Medipix positron
detector with real-time visualisation. The detector yielded far
superior signal-to-noise ratios compared to a conventional
radio-HPLC detector for the measurement of the 68Ga-citrate
PET radiotracer. Crucially, no shielding is required since it
detects only short-ranged positrons rather than gamma rays.
Variants of the Medipix detector can be purchased commercially
(e.g. from Advacam, X-Ray Imatek or Jablotron) for not a great deal
more than conventional detectors, although licensing and terms of
use must be considered. These factors make the platform ideal for
miniaturised, monolith-based radio-TLC and radio-HPLC applica-
tions in an integrated microfluidic QC system.
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